Skip to content

6-KAccepted Sep 26, 3:01 PM ET

PHAXIAM Therapeutics S.A. 6-K

PHAXIAM Therapeutics S.A.

Accepted (ET)

3:01 PM

Sep 26, 2023

Filed

Sep 26, 2023

Documents

66

Size

7.7 MB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.